- McKesson veteran Marc Owen to become Chairman of the Celesio Management Board, effective July 16, 2014
- Dr Marion Helmes to continue in her current capacity as Speaker of the Management Board and CFO and additionally take over the responsibilities as COO; both through July 15, 2014
- Alain Vachon, currently Senior Vice President and CFO of McKesson U.S. Pharmaceutical, to become CFO of Celesio, effective July 16, 2014
- Martin Fisher, COO of Celesio, has resigned, effective May 22, 2014
The Supervisory Board of Celesio AG (“Celesio”) today has appointed Marc Owen Chairman of the Management Board, effective July 16, 2014. Owen will succeed Marion Helmes, currently Speaker of the Management Board and Chief Financial Officer of Celesio. Helmes will continue in her current capacity as Speaker of the Management Board and CFO through July 15, 2014, and consults with Celesio for a brief period thereafter to support the transition to new leadership. This decision was taken in full mutual agreement.
The Supervisory Board also decided that Alain Vachon, Senior Vice President and Chief Financial Officer of McKesson U.S. Pharmaceutical, will become new CFO of Celesio, effective July 16, 2014. Martin Fisher, Chief Operating Officer of Celesio, has resigned, effective May 22, 2014. Helmes will take over the responsibilities as Celesio COO additionally through July 15, 2014.
“I am extremely pleased to announce Marc Owen’s appointment as Chairman of the Management Board,” said John H. Hammergren, Chairman of the Supervisory Board of Celesio. “Marc is one of the most talented leaders and strategists in the healthcare industry. With his broad experience across all sectors of healthcare, combined with his deep knowledge of the European market, Marc is uniquely qualified to lead Celesio as it becomes part of McKesson and begins the next exciting chapter in its history.”
“I would like to thank Marion for her leadership over the past nine months and her partnership in ensuring a smooth transition,” added Hammergren. “Marion was instrumental in bringing McKesson’s acquisition of Celesio to fruition and driving significant progress with Celesio’s key strategic initiatives, including the European Pharmacy Network. I wish her great success in her future endeavors.”
“I am very proud to have helped put together this deal, which makes Celesio part of a global powerhouse and thus opens up huge growth opportunities for the benefit of shareholders, employees and customers,” said Dr Helmes.
Marc Owen is currently President of McKesson Specialty Health, a division of McKesson Corporation that distributes oncology and other specialty drugs to physicians and other healthcare providers throughout North America. Under Owen’s leadership, McKesson Specialty Health has achieved a leading market share position in community oncology, expanded the number of physicians in The US Oncology Network, and grown McKesson’s presence in other specialties, including rheumatology and ophthalmology.
Before becoming President of McKesson Specialty Health, Owen served as McKesson’s Executive Vice President of Corporate Strategy and Business Development, guiding McKesson’s overall corporate strategy, including mergers and acquisitions, international expansion and internal innovation. Prior to joining McKesson, Owen was a Senior Partner at McKinsey, advising pharmaceutical manufacturers, healthcare providers, distributors and technology companies, including McKesson, for more than a decade. Owen began his career with McKinsey in the firm’s London office and holds undergraduate and graduate degrees from Oxford University and an MBA from Stanford University.
Alain Vachon, currently Senior Vice President and CFO of McKesson U.S. Pharmaceutical, will bring more than 25 years of financial experience to his new role as CFO of Celesio. In his present role with McKesson U.S. Pharmaceutical, Vachon oversees all financial and accounting operations, as well as McKesson’s financial shared service center, which provides finance support to all McKesson business units. During his tenure, Vachon has helped reduce McKesson’s working capital by more than U.S. $2 billion.
Previously, Vachon held several leadership positions in McKesson Canada, including Vice President and General Manager for McKesson’s eastern Canada division, and CFO of McKesson Canada. Before joining McKesson, Vachon was a Certified Public Accountant with Price Waterhouse. Vachon is a graduate of l’Université du Québec at Montreal where he obtained a Bachelor Degree in Administration.
About Celesio Group
Celesio is a leading international wholesale and retail company and provider of logistics and services to the pharmaceutical and healthcare sectors. The proactive and preventive approach ensures that patients receive the products and support that they require for optimum care. With some 39,000 employees, Celesio operates in 14 countries around the world. Every day, the group serves over 2 million customers – at 2,200 pharmacies of its own and 4,200 participants in brand partnership schemes. With approximately 130 wholesale branches, Celesio supplies 65,000 pharmacies and hospitals every day with up to 130,000 pharmaceutical products. The services benefit a patient pool of about 15 million per day.